DocGo gets Nasdaq extension to January 25, 2027 to regain $1.00 minimum bid price
DocGo received a Nasdaq letter on July 28, 2026, granting an additional 180 calendar days, until January 25, 2027, to regain compliance with the minimum bid price requirement. The company's stock must close at or above $1.00 for at least 10 consecutive business days to regain compliance, and the company says it cannot assure it will do so in time. Shareholders should note that the company may pursue a reverse stock split, which stockholders approved at the June 16, 2026 annual meeting.
Key points
- Nasdaq granted an additional 180 calendar days, until January 25, 2027, to meet the $1.00 minimum bid price requirement
- Compliance requires a closing bid price of at least $1.00 for a minimum of 10 consecutive business days
- Stockholders approved a reverse stock split at ratios of 1-for-5 to 1-for-10 at the June 16, 2026 annual meeting, with the final ratio to be set by the Board
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.